Xspray Pharma: Adding capital to the war chest

Research Note

2019-12-06

09:00

Xspray has carried out a directed share issue which will generate approximately SEK 122 million before transaction fees. The capital puts Xspray in a stronger position as they move closer to market launch with HyNap-Dasa.

JS

Jakob Svensson

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.